Three companies are slated to open trading this week.
Fangdd Network Group (NASDAQ:DUO), an online real estate marketplace based in Shenzhen China, plans to offer 7 million shares at a price between $13 and $16 per share in order to raise $98 million.
The company claims to be the largest real estate marketplace in China, featuring 911,000 of the country’s roughly 2 million agents on its platform as of December 31.
In June, the company had 131 million properties in its database, one of the largest such databases in China according to Frost & Sullivan.
Oyster Point Pharma Inc (NASDAQ:OYST), a Princeton, New Jersey-based biopharmaceutical company developing therapies to treat ocular surface diseases, hopes to raise $85 million by offering 5 million shares at a price between $16 and $18 per share.
Its lead candidate, varenicline, is a nasal spray designed to treat the signs and symptoms of dry eye disease. In a Phase 2 trial of 182 patients, varenicline demonstrated statistically significant improvements over a placebo.
The company began a Phase 3 trial in July and expects topline results in mid-2020 with a potential New Drug Application to follow.
CNS Pharmaceuticals Inc (NASDAQ:CNSP), a Houston biotechnology company focused on brain cancer therapies, is looking to raise $10 million by offering 2.1 million shares at a price between $4 and $6 per share.
The company is developing drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its lead drug candidate, Berubicin, is designed to treat glioblastoma, a type of brain cancer currently considered to be incurable, the company said.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel